Figure 4From: The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin The effect of enoxaparin and rivaroxaban concentration on Runx2 and BMP2 mRNA expression following 1 and 7 days of treatment. Data are presented as mean fold change ± the standard deviation. *p < 0.05; **p < 0.01 from Student's t-test relative to the control treatment (n = 3).Back to article page